Navigation Links
Smallpox Vaccine May Help Fight Cervical Cancer

A modified version of the smallpox vaccine is being tested against cervical cancer. Human papilloma virus (HPV) is associated with 95% of cervical cancer cases, but not everyone with the virus develops the cancer. Cervical cancer affects about 465,000 women worldwide each year and causes 300,000 deaths. If it is diagnosed and treated in its earliest stages there is a high survival rate. //

Doctors at Britain's Cancer Research Campaign hope the vaccine will boost the immune system's response to the human papilloma virus (HPV), which is linked to most cases of the illness, and prevent early cell changes from developing into cervical cancer. A modified version of the smallpox vaccine is being used because it has been shown to produce the type of immune response that the researchers are looking for.

In addition to treating women with pre-cancerous cell changes, scientists are also working on vaccines for women with advanced disease and preventive vaccines to protect young girls from becoming infected with HPV.


'"/>




Page: 1

Related medicine news :

1. Smallpox as Biological Weapons?
2. Is Smallpox Threat Real ?
3. Smallpox Would Spread Rapidly
4. Drug Firm Offers to Donate Smallpox Vaccine
5. Penn Researchers Throw Light on the Structure Of Smallpox Virus Protein
6. Toddler Infected With Rare Side Effect of Smallpox Vaccine
7. Vaccine to quit smoking?
8. First Vaccine Designed for Africa Cleared for Testing in Humans
9. Vaccine for Alzheimer’s diseas
10. Health Officials Recommend Flu Vaccine
11. Panacea Biotech To Market Anthrax Vaccine

Post Your Comments:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Churchill C...Award For Leadership to J.W. "Bill" Marriott for h...ugh progressive free market practices and fosterin... Mr. Marriott will receive his award at a ceremony...ton D.C. Four Seasons Hotel. ,, "This is a tes...
(Date:11/9/2009)...elped men and women almost equally, study finds, ...he widely used clot-dissolving drug Plavix (clopid... analysis of major clinical trials has found. ,...in treating both men and women with this very impo...of cardiovascular thrombosis at New York Universit...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it...tion, according to TOPS Club, Inc. (Take Off Pound...anization. , (Vocus) Nove...omes to preventing or improving a diabetes conditi...Sensibly), the nonprofit weight-loss support organ...
(Date:11/9/2009)...BANON, Tenn., Nov. 9 Health Connec...nced it will host their inaugural Hospital O.R. an... at the Marriott Renaissance Hotel in Nashville, T...re than 100 hospital operating room directors and ...alth systems in the country. Some of the confirmed...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...al shows novel compound blocks enzyme triggering c...4 (HealthDay News) -- A drug designed to lessen mu... safety tests in humans. , The drug, known as KAI-...ervention (PCI). PCI is a set of procedures includ...
...reading of screening mammograms with computer-aide...ading and yields a higher sensitivity than the fir...o a study conducted by researchers at Charlotte Ra...onsisted of the mammogram being first read by sub-...
...echnique that combines bone marrow removal and inj...of new bone at targeted locations in the body, it ... in Tissue Engineering. , "This could radically c...gns Vignery , associate professor of orthopedics ...
...O(TM) Beverage Provides Refreshing Taste with Bene... International today,launches HIRO(TM) Super Fruit...its popular HIRO(TM) ready-to-drink noni-based bev...pe., HIRO Super Fruits Sparkling Black Currant is...
..., Feb. 14 Today, the Centers for,Disease Control ...sting,performed on occupied FEMA travel trailers. ... testified before the Committee on Homeland,Securi...associated with prolonged formaldehyde exposure ca...
...aeli scientist, Dr. Siegal Sadetzki, has found a l...f tumors. , Dr. Sadetzki, a physician, epidemiol...ed the results of a study recently in the American...rs of the salivary gland. , Those who used a cel...
Other Medicine News:Health News:Drug Cuts Muscle Damage After Heart Attack 2Health News:Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive 2Health News:Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant 2Health News:Thompson Demands Solution to Formaldehyde Trailer Crisis 2Health News:Cell phone-cancer link found by Tel Aviv University scientist 2
(Date:11/9/2009)...all/ -- Cardiac Science Corporation (Nasdaq: ...brillator ( AED ) and diagnostic cardiac monitor...ion for the third quarter ended September 30, 2009...also recorded a charge of $18.5 million for an AED....0 million to increase its valuation allowance aga...
(Date:11/9/2009)... 9 Hill-Rom (NYSE: HR...ion of a joint venture that will focus on the sale...ace replacement systems that are intended to be so...or surfaces that are technologically obsolete or a...l leader in patient support systems and related te...
(Date:11/9/2009)...all/ -- Landauer, Inc. (NYSE: LDR ), a recogniz...monitoring services, today announced the completio...term strategic priorities. ,, "We are pleased t...tions, Inc. (GPS) and Gammadata Mattenknik AB (GDM...er. "These acquisitions position Landauer to execu...
Breaking Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 1SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 2SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 3Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 1Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 2Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 3Baptist Medical Center 26apos 3Bs Patient Outcomes Among Highest in the Nation According to Independent Study 59425 4One Day Management Training Program to be Offered November 18 in Boston Area 59420 1One Day Management Training Program to be Offered November 18 in Boston Area 59420 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 3One Day Management Training Program to be Offered November 18 in Boston Area 59420 4One Day Management Training Program to be Offered November 18 in Boston Area 59420 5
...nificant reduction in sedation during the,early po...stically significant reduction in nausea in the fe...bridge, UK, 8th June 2007 - CeNeS Pharmaceuticals ...cal company, announces,additional data from post-h... of M6G (morphine-6-glucuronide) in over 500 patie...
...BUSINESS WIRE)--Jun 8, 2007 - NuPathe Inc., a,priv... announced,positive results from an initial Phase ...r acute migraine being developed,by NuPathe., NP10...ontophoretic transdermal technology with sumatript... migraine in the United,States. Sumatriptan is als...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
ALLEGRO Analyzer
RESTASIS®
LADARWave® Aberrometer
ZYMAR™ 2.5 mL
Medicine Products: